BB Biotech AG Cash Flow Conversion Efficiency

Latest as of June 2026: -0.049x

BB Biotech AG cash flow conversion efficiency. Based on the latest financial reports, BB Biotech AG (BION) has a cash flow conversion efficiency ratio of -0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-150.88 Million ≈ $-190.75 Million USD) by net assets (CHF3.08 Billion ≈ $3.90 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of BB Biotech AG (2003–2025)

Cash flow conversion efficiency of BB Biotech AG from 2003 to 2025. This chart illustrates how BB Biotech AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BION stock price for real-time trading data and today's change.

BB Biotech AG Cash Flow Conversion Ratio Explained

BB Biotech AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BB Biotech AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BB Biotech AG ranked by their cash flow conversion efficiency. Also see how much is BB Biotech AG worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Beijing Shiji Information Technology Co Ltd SHE:002153	0.060x
GCL Energy Technology Co Ltd SHE:002015	0.107x
Bel Fuse B Inc NASDAQ:BELFB	0.018x
Lisi S.A PA:FII	0.057x
Bangkok Expressway and Metro Public Company Limited BK:BEM	-0.168x
Focuslight Technologies Inc. A SHG:688167	N/A
Van Lanschot NV AS:VLK	0.878x
Advance Auto Parts Inc NYSE:AAP	-0.009x

Annual Cash Flow Conversion Efficiency for BB Biotech AG (2003–2025)

The table below shows the annual cash flow conversion efficiency of BB Biotech AG from 2003 to 2025. Review BION free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF2.78 Billion ≈ $3.51 Billion	CHF309.14 Million ≈ $390.84 Million	0.111x	-16.48%
2024-12-31	CHF2.29 Billion ≈ $2.89 Billion	CHF304.56 Million ≈ $385.05 Million	0.133x	+41.78%
2023-12-31	CHF2.32 Billion ≈ $2.94 Billion	CHF218.28 Million ≈ $275.96 Million	0.094x	+170.53%
2022-12-31	CHF2.69 Billion ≈ $3.40 Billion	CHF-357.81 Million ≈ $-452.37 Million	-0.133x	-8.23%
2021-12-31	CHF3.29 Billion ≈ $4.16 Billion	CHF-404.81 Million ≈ $-511.79 Million	-0.123x	-282.90%
2020-12-31	CHF3.90 Billion ≈ $4.93 Billion	CHF262.45 Million ≈ $331.81 Million	0.067x	+6.19%
2019-12-31	CHF3.39 Billion ≈ $4.29 Billion	CHF215.02 Million ≈ $271.84 Million	0.063x	+138.78%
2018-12-31	CHF2.88 Billion ≈ $3.65 Billion	CHF-471.34 Million ≈ $-595.90 Million	-0.163x	-184.11%
2017-12-31	CHF3.54 Billion ≈ $4.47 Billion	CHF687.50 Million ≈ $869.19 Million	0.194x	+172.74%
2016-12-31	CHF3.00 Billion ≈ $3.80 Billion	CHF-802.07 Million ≈ $-1.01 Billion	-0.267x	-262.76%
2015-12-31	CHF3.98 Billion ≈ $5.03 Billion	CHF652.82 Million ≈ $825.34 Million	0.164x	-61.02%
2014-12-31	CHF3.49 Billion ≈ $4.42 Billion	CHF1.47 Billion ≈ $1.86 Billion	0.421x	-4.28%
2013-12-31	CHF2.12 Billion ≈ $2.68 Billion	CHF931.83 Million ≈ $1.18 Billion	0.440x	+47.54%
2012-12-31	CHF1.23 Billion ≈ $1.56 Billion	CHF367.83 Million ≈ $465.04 Million	0.298x	+76.14%
2011-12-31	CHF1.00 Billion ≈ $1.27 Billion	CHF169.52 Million ≈ $214.32 Million	0.169x	+992.62%
2010-12-31	CHF1.23 Billion ≈ $1.56 Billion	CHF-23.41 Million ≈ $-29.60 Million	-0.019x	-117.13%
2009-12-31	CHF1.52 Billion ≈ $1.92 Billion	CHF167.84 Million ≈ $212.19 Million	0.111x	-67.30%
2008-12-31	CHF1.50 Billion ≈ $1.90 Billion	CHF509.39 Million ≈ $644.01 Million	0.339x	+197.58%
2007-12-31	CHF1.77 Billion ≈ $2.23 Billion	CHF201.02 Million ≈ $254.14 Million	0.114x	+1394.02%
2006-12-31	CHF2.25 Billion ≈ $2.85 Billion	CHF-19.80 Million ≈ $-25.04 Million	-0.009x	-226.35%
2005-12-31	CHF2.28 Billion ≈ $2.88 Billion	CHF-6.14 Million ≈ $-7.76 Million	-0.003x	-104.81%
2004-12-31	CHF1.91 Billion ≈ $2.42 Billion	CHF107.32 Million ≈ $135.68 Million	0.056x	+163.12%
2003-12-31	CHF1.94 Billion ≈ $2.45 Billion	CHF-172.22 Million ≈ $-217.73 Million	-0.089x	--

About BB Biotech AG

SW:BION Switzerland Biotechnology

Market Cap

$3.53 Billion

CHF2.80 Billion CHF

Market Cap Rank

#4851 Global

#78 in Switzerland

Share Price

CHF50.70

Change (1 day)

-1.17%

52-Week Range

CHF40.10 - CHF56.80

All Time High

CHF78.42